- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Rise of ACOs Leads to AAAHC Reorganization
The rise of accountable care organizations and continued healthcare consolidation have led to a plan to reorganize the Skokie, Ill.-based Accreditation Association for Ambulatory Health Care, which includes splitting the organization into two parts and launching a pilot program to accredit small hospitals.
Read the full story: http://hcp.lv/I9k6kP
Source: ModernHealthcare.com
“The movement to accountable care organizations and other recent trends has led to more health systems reabsorbing primary-care physicians and free-standing ambulatory-care settings back into the hospital,” John Burke, AAAHC president and CEO, said in a news release (PDF). “With our experience as the leader in ambulatory-care accreditation, AAAHC saw an opportunity to improve patient care by offering a program that addresses both outpatient and inpatient hospital care and the ambulatory care offered by small hospital systems.”
Streamlining "Brain-to-Vein" Time, Patient Selection, Imperative for Implementing CAR T for MM
March 21st 2025Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Overcoming CAR T Manufacturing Failure in LBCL
March 21st 2025Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen receptor (CAR) T-cell administration in patients with relapsed/refractory large B-cell lymphoma (LBCL).
Read More
